Orthopedic Devices Market - Global Forecast To 2030
商品番号 : SMB-30790
| 出版社 | MarketsandMarkets |
| 出版年月 | 2025年3月 |
| ページ数 | 441 |
| 図表数 | 493 |
| 価格タイプ | シングルユーザライセンス |
| 価格 | USD 12,000 |
| 種別 | 英文調査報告書 |
Report Overview
The global orthopedic devices market is expected to reach 68.51 billion by 2030 from USD 51.61 billion in 2024, at a CAGR of 4.8% from 2024 to 2030.
世界の整形外科用機器市場は、2024年の516億1,000万米ドルから2030年までに685億1,000万米ドルに達し、2024年から2030年にかけて4.8%のCAGRで成長すると予想されています。
The orthopedic devices market is growing due to increasing cases of musculoskeletal disorders, increasing geriatric population, and rising demand for minimally invasive surgical techniques. Osteoarthritis, rheumatoid arthritis, and osteoporosis are increasingly prevalent, especially among the elderly, and are increasing the need for joint replacement and fracture fixation equipment. Adoption of 3D printing, robotic-assisted surgery, and bioresorbable & smart implants, are improving patient outcomes. Osteoarthritis, rheumatoid arthritis, and osteoporosis are highly prevalent, especially among the elderly, and are driving demand for joint replacement and fracture fixation devices.
整形外科用機器市場は、筋骨格系疾患の増加、高齢者人口の増加、低侵襲手術技術の需要の高まりにより成長しています。変形性関節症、関節リウマチ、骨粗鬆症は、特に高齢者の間で蔓延しており、関節置換および骨折固定機器の必要性が高まっています。3Dプリント、ロボット支援手術、生体吸収性およびスマートインプラントの採用により、患者の転帰が改善されています。変形性関節症、関節リウマチ、骨粗鬆症は、特に高齢者の間で蔓延しており、関節置換および骨折固定機器の需要を促進しています。
“The joint replacement devices segment to hold the largest share of the market in 2023.”
Joint replacement devices are devices implanted to substitute diseased or damaged joints, mainly in the hip, knee, and shoulder, to decrease pain and enhance movement. They are driven by increasing obesity, which results in joint decay, and by more young people requiring early intervention. Technologies such as real-time tracking smart implants and personalized 3D-printed implants are improving surgical precision and patient recovery. Additionally, an increase in healthcare expenditure, supportive reimbursement policies, and government strategies enhance orthopedic care.
“The knee & thigh segment to hold the largest share of the market in 2023.”
The knee & thigh segment accounts for the largest share of the orthopedic devices market by site due to the high incidence of fractures in knee, osteoarthritis, and osteoporosis. Knee replacement surgeries are the most common orthopedic procedures conducted, fueled by rising life expectancy and the increasing number of populations affected with degenerative joint diseases. Moreover, innovations in implant materials, minimally invasive surgical procedures, and robotic-assisted surgeries have improved the quality of life of patients. The increasing prevalence of sports injuries also drives the requirement for knee & thigh implants.
“The hospitals and surgical centers segment to hold the largest share of the market in 2023.”
The segment of hospitals and surgical centers has the highest market share in orthopedic devices because they play a pivotal role in delivering high-end and specialized treatments for orthopedic conditions in patients. They provide technologically advanced orthopedic procedures, such as joint replacements and fracture fixations, which make them the first choices for orthopedic procedures. Also, hospitals and surgery centers usually possess the necessary funds to manage complicated cases, conduct minimally invasive procedures, and administer post-procedure treatment, all of which sustain demand for orthopedic devices.
“The market in the APAC region is expected to register the highest growth rate for orthopedic devices in 2023.”
The orthopedic devices market covers five key geographies—North America, Europe, Asia Pacific, Latin America, and the Middle East and Africa. In 2023, a significant market share for orthopedic devices was held by the market in the North American region, comprising the US and Canada. On the other hand, the Asia Pacific market is estimated to register the highest growth rate during the forecast period.
The Asia Pacific is experiencing the most rapid growth in the market for orthopedic devices due to a combination of factors such as a rapidly growing elderly population, increased disposable incomes, and growth in access to healthcare. The growth in musculoskeletal disorders such as arthritis and osteoporosis, particularly in countries such as Japan, China, and India, is driving the adoption of orthopedic treatments. Furthermore, the region is also experiencing a boost in health care infrastructure as well as new-age technology applications, such as minimally invasive procedures and robotic-assisted surgeries, that are improving surgical outcomes. Additionally, rising medical tourism in countries such as India and Thailand, along with government actions to enhance the health care infrastructure, is also contributing to growth in the market in the region.
A breakdown of the primary participants referred to for this report is provided below:
- By Company Type: Tier 1– 30%, Tier 2– 42%, and Tier 3– 28%
- By Designation: Directors– 10%, Managers– 14%, and Others– 76%
- By Region: North America– 40%, Europe– 30%, Asia Pacific– 22%, Latin America- 6%, MEA- 2%
The prominent players in the Orthopedic devices market are Stryker Corporation (United States), Johnson & Johnson (United States), Globus Medical, Inc. (United States), Medacta International SA (Switzerland), Zimmer Biomet Holdings, Inc. (United States), Arthrex, Inc. (United States), Acumed LLC (United States), Enovis Corporation (United States), CONMED Corporation (United States), B. Braun Melsungen AG (Germany), Meril Life Sciences Pvt. Ltd. (India), (Ireland), Paragon 28, Inc. (United States), Smith & Nephew plc (United Kingdom), Orthofix Medical Inc. (United States).
Research Coverage
This market research report analyzes the orthopedic devices market along several different segments, such as product type, application, end-user, region, site and geography. The report further sheds light on market growth-driving factors, mentions opportunities and threats, and presents analysis of competitive rivalry of leading companies. It further studies micro markets by focusing on growth tendencies and predicts revenues for industry segments for five leading geographies, along with corresponding countries.
Reasons to Buy the Report
The report would assist both small and new businesses in comprehending the market pattern, which can help them grow their market place. Businesses procuring the report can implement any one or several of the approaches discussed to extend their market position.
This report provides insights on the following pointers:
- Key drivers (increasing requirement for minimally invasive orthopedic surgical procedures and increasing number of sports injuries, increasing incidence of orthopedic diseases and disorders and increasing research funding and restraints (risk and complications of orthopedic surgical procedures, exorbitant cost of orthopedic treatments, reduced reimbursements for orthopedic surgical procedures), opportunities (increasing number of hospitals and trend towards outpatient care, innovations in robotic-assisted orthopedic surgeries and 3D printing), and challenges (skilled orthopedic surgeons shortages) fueling the market growth of orthopedic devices
- Product Development/Innovation: In-depth study of emerging technologies, research & development programs, and new product & service launches in the orthopedic devices market
- Market Growth: In-depth insights into remunerative markets report analyzes the orthopedic devices market across varied geographies.
- Market Diversification: Detailed analysis of new products, unexplored geographies, latest trends, and investments in the orthopedic devices market
- Competitive Analysis: In-depth analysis of market shares, growth strategies, and services of leading players, such as Zimmer Biomet Holdings, Inc. (US), Stryker Corporation (US), Johnson & Johnson MedTech (US), Smith+Nephew (UK), B. Braun (Germany).
Table of Contents
1 INTRODUCTION 34
1.1 STUDY OBJECTIVES 34
1.2 MARKET DEFINITION 34
1.3 STUDY SCOPE 35
1.3.1 MARKETS CONSIDERED AND REGIONS COVERED 35
1.3.2 INCLUSIONS AND EXCLUSIONS 36
1.3.3 YEARS CONSIDERED 37
1.3.4 CURRENCY CONSIDERED 37
1.3.5 STAKEHOLDERS 37
1.4 SUMMARY OF CHANGES 38
2 RESEARCH METHODOLOGY 39
2.1 RESEARCH DATA 39
2.2 RESEARCH DESIGN 40
2.2.1 SECONDARY RESEARCH 40
2.2.1.1 Key data from secondary sources 42
2.2.2 PRIMARY RESEARCH 42
2.2.2.1 Primary sources 43
2.2.2.2 Key industry insights 44
2.3 MARKET SIZE ESTIMATION 45
2.3.1 BOTTOM-UP APPROACH 46
2.3.1.1 Approach 1: Company revenue estimation approach 47
2.3.1.2 Approach 2: Customer-based market estimation 47
2.3.1.3 Approach 3: Top-down approach 48
2.3.1.4 Approach 4: Primary interviews 48
2.4 GROWTH FORECAST 49
2.5 DATA TRIANGULATION AND MARKET BREAKDOWN 51
2.6 MARKET SHARE ASSESSMENT 52
2.7 RESEARCH ASSUMPTIONS & LIMITATIONS 52
2.7.1 ASSUMPTIONS 52
2.7.2 LIMITATIONS 53
2.8 RISK ASSESSMENT 53
3 EXECUTIVE SUMMARY 54
4 PREMIUM INSIGHTS 59
4.1 ORTHOPEDIC DEVICES MARKET OVERVIEW 59
4.2 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT 60
4.3 EUROPE: ORTHOPEDIC DEVICES MARKET, BY SITE 61
4.4 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY END USER (USD MILLION) 62
4.5 ORTHOPEDIC DEVICES MARKET, BY REGION 62
5 MARKET OVERVIEW 63
5.1 INTRODUCTION 63
5.2 MARKET DYNAMICS 63
5.2.1 DRIVERS 64
5.2.1.1 Rising cases of orthopedic diseases and disorders 64
5.2.1.2 Increasing adoption of telemedicine and telesurgery 64
5.2.1.3 Increasing demand for minimally invasive orthopedic
surgical procedures 65
5.2.1.4 Growing number of sports and accident-related orthopedic injuries 65
5.2.1.5 Rising geriatric population and projected increase in age-related bone disorders 65
5.2.2 RESTRAINTS 66
5.2.2.1 Risks and complications associated with orthopedic
surgical procedures 66
5.2.2.2 High cost of orthopedic devices and treatments 66
5.2.3 OPPORTUNITIES 66
5.2.3.1 Growing focus on orthobiologics 66
5.2.3.2 Rising number of hospitals and shift toward outpatient care 67
5.2.3.3 Increasing use of robotics and 3D printing in orthopedics 67
5.2.4 CHALLENGES 68
5.2.4.1 Dearth of orthopedic surgeons 68
5.3 ECOSYSTEM ANALYSIS 69
5.4 SUPPLY CHAIN ANALYSIS 70
5.4.1 MANUFACTURERS 71
5.4.1.1 Prominent companies 71
5.4.1.2 Small and medium-sized enterprises 71
5.4.2 END USERS 71
5.5 VALUE CHAIN ANALYSIS 71
5.5.1 RESEARCH AND DEVELOPMENT 71
5.5.2 PROCUREMENT AND PRODUCT DEVELOPMENT 71
5.5.3 MARKETING, SALES AND DISTRIBUTION, AND POST-SALES SERVICES 72
5.6 TECHNOLOGY ANALYSIS 73
5.6.1 KEY TECHNOLOGIES 73
5.6.1.1 Robotic-assisted technology 73
5.6.2 COMPLEMENTARY TECHNOLOGIES 73
5.6.2.1 Imaging systems and software 73
5.6.2.2 Fluoroscopy 74
5.6.3 ADJACENT TECHNOLOGIES 74
5.6.3.1 AI and machine learning 74
5.7 KEY CONFERENCES AND EVENTS IN 2025–2026 75
5.8 TRADE ANALYSIS 76
5.8.1 IMPORT DATA FOR HS CODE 902110 76
5.8.2 EXPORT DATA FOR HS CODE 902110 77
5.9 PATENT ANALYSIS 79
5.10 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
5.11 PORTER’S FIVE FORCES ANALYSIS 81
5.11.1 OVERVIEW 81
5.11.2 THREAT OF NEW ENTRANTS 82
5.11.3 THREAT OF SUBSTITUTES 82
5.11.4 BARGAINING POWER OF SUPPLIERS 83
5.11.5 BARGAINING POWER OF BUYERS 83
5.11.6 INTENSITY OF COMPETITIVE RIVALRY 83
5.12 KEY STAKEHOLDERS AND BUYING CRITERIA 83
5.12.1 KEY STAKEHOLDERS 83
5.12.2 KEY BUYING CRITERIA 84
5.13 CASE STUDY ANALYSIS 85
5.13.1 CASE STUDY 1: ANTERIOR CRUCIATE LIGAMENT RECONSTRUCTION AND CHONDROPLASTY OF KNEE 85
5.13.2 CASE STUDY 2: EFFECTIVENESS OF OSTEOPATHY IN
TREATING SPORTS INJURIES 86
5.13.3 CASE STUDY 3: TOTAL HIP REPLACEMENT WITH AVASCULAR NECROSIS 87
5.14 PRICING ANALYSIS 87
5.14.1 AVERAGE SELLING PRICE, BY REGION 88
5.14.2 AVERAGE SELLING PRICE, BY KEY PLAYER 89
5.15 REIMBURSEMENT SCENARIO 89
5.16 INVESTMENT & FUNDING SCENARIO 91
5.17 UNMET NEEDS AND KEY PAIN POINTS 93
5.18 REGULATORY LANDSCAPE 93
5.18.1 REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
5.18.2 REGULATORY FRAMEWORK 96
5.18.2.1 North America 96
5.18.2.1.1 US 96
5.18.2.1.2 Canada 97
5.18.2.2 Europe 99
5.18.2.3 Asia Pacific 100
5.18.2.3.1 Japan 100
5.18.2.3.2 China 101
5.18.2.3.3 India 102
5.19 IMPACT OF AI ON ORTHOPEDIC DEVICES MARKET 103
5.20 ADVANCED PROSTHETICS 104
5.21 SMART IMPLANTS 104
6 ORTHOPEDIC DEVICES MARKET, BY PRODUCT 105
6.1 INTRODUCTION 106
6.2 ORTHOPEDIC REPLACEMENT DEVICES 107
6.2.1 FOOT & ANKLE REPLACEMENT DEVICES 109
6.2.1.1 Growing number of foot and ankle replacement procedures to
fuel market growth 109
6.2.2 KNEE REPLACEMENT DEVICES 110
6.2.2.1 Ongoing innovation in knee implants to support growth 110
6.2.3 HIP REPLACEMENT DEVICES 111
6.2.3.1 Rising number of hip fractures and increasing success rate of hip arthroplasty to support market growth 111
6.2.4 HAND & WRIST REPLACEMENT DEVICES 112
6.2.4.1 Rising demand to support market growth 112
6.2.5 ELBOW REPLACEMENT DEVICES 113
6.2.5.1 Increasing frequency of elbow joint fractures and growth in elderly population to drive market 113
6.2.6 SHOULDER REPLACEMENT DEVICES 114
6.2.6.1 Launch of new shoulder replacement implants and rising popularity of reverse shoulder arthroplasty to support growth 114
6.2.7 OTHER REPLACEMENT DEVICES 115
6.3 SPINAL IMPLANTS & SURGICAL DEVICES 115
6.3.1 SPINAL FUSION DEVICES 118
6.3.1.1 Advantages of anterior thoracic & anterior lumbar fusion to support market growth 118
6.3.2 SPINAL NON-FUSION DEVICES 118
6.3.2.1 Increasing incidence of degenerative diseases in younger populations to drive market 118
6.4 ORTHOPEDIC FIXATION DEVICES 119
6.4.1 INTERNAL FIXATION DEVICES 122
6.4.1.1 Reduced incidence of malunion or nonunion of injured bones to support adoption 122
6.4.2 EXTERNAL FIXATION DEVICES 123
6.4.2.1 Increasing incidence of upper and lower-extremity injuries
to drive market 123
6.5 ARTHROSCOPY INSTRUMENTS 124
6.5.1 RISING ARTHROSCOPY TREATMENT PROCEDURES TO
SUPPORT MARKET GROWTH 124
6.6 ORTHOPEDIC BRACES & SUPPORTS 127
6.6.1 KNEE BRACES & SUPPORTS 129
6.6.1.1 Growing geriatric and obese populations to support market growth 129
6.6.2 ANKLE BRACES & SUPPORTS 130
6.6.2.1 Clinical benefits and favorable recommendations from physicians to support market growth 130
6.6.3 FOOT WALKERS & ORTHOSES 131
6.6.3.1 Rapidly growing diabetic population and subsequent rise in prevalence of foot problems to drive market 131
6.6.4 BACK, HIP, AND SPINE BRACES & SUPPORTS 132
6.6.4.1 Rising incidence of lower spine disorders to propel market 132
6.6.5 SHOULDER BRACES & SUPPORTS 133
6.6.5.1 Rising prevalence of shoulder arthritis to support market growth 133
6.6.6 ELBOW BRACES & SUPPORTS 134
6.6.6.1 Rising prevalence of elbow-related osteoarthritis to drive adoption 134
6.6.7 HAND & WRIST BRACES & SUPPORTS 135
6.6.7.1 Increasing incidence of hand and wrist injuries to drive market 135
6.6.8 FACIAL BRACES & SUPPORTS 135
6.6.8.1 Rising number of plastic surgeries to propel market 135
6.7 ORTHOPEDIC PROSTHETICS 136
6.7.1 SOLID ANKLE CUSHION HEEL PROSTHESES 139
6.7.1.1 Inexpensive, durable, and virtually maintenance-free properties to boost adoption 139
6.7.2 SINGLE-AXIAL PROSTHESES 139
6.7.2.1 Need for periodic servicing to limit adoption 139
6.7.3 MULTI-AXIAL PROSTHESES 140
6.7.3.1 High cost of multi-axial prostheses to limit market growth 140
6.7.4 DYNAMIC RESPONSE PROSTHESES 141
6.7.4.1 Low weight and support for active lifestyles to drive adoption 141
6.7.5 MICROPROCESSOR-CONTROLLED PROSTHESES 141
6.7.5.1 Higher stability and motion to support market growth 141
6.8 BONE GRAFT SUBSTITUTES 142
6.8.1 AUTOGRAFTS 145
6.8.1.1 High success rate in anterior and posterior cervical arthrodesis to support growth 145
6.8.2 ALLOGRAFTS 145
6.8.2.1 Reduced post-operative hospital stay coupled with limited requirement of incisions to drive market growth 145
6.8.3 SYNTHETIC GRAFTS 146
6.8.3.1 Reduced risk of disease transmission and high degree of customization to support market growth 146
6.9 ORTHOBIOLOGICS 147
6.9.1 VISCOSUPPLEMENTATION PRODUCTS 149
6.9.1.1 Cost-effectiveness of products to support market growth 149
6.9.2 DEMINERALIZED BONE MATRIX 150
6.9.2.1 Widespread acceptance in orthopedic surgery to fuel market growth 150
6.9.3 BONE MORPHOGENETIC PROTEINS 151
6.9.3.1 Osteoinductive properties and better integration in joint procedures to fuel market growth 151
6.9.4 PLASMA-RICH PROTEIN 152
6.9.4.1 Rising application of PRP in sports injuries to support market growth 152
6.9.5 BONE MARROW ASPIRATE CONCENTRATE 152
6.9.5.1 Minimally invasiveness procedure and less downtime to
propel growth 152
7 ORTHOPEDIC DEVICES MARKET, BY PROCEDURE (VOLUME) 154
7.1 JOINT REPLACEMENT SURGERY PROCEDURAL VOLUME, BY SITE 155
7.2 ARTHROSCOPY PROCEDURAL VOLUME, BY SITE 157
8 ORTHOPEDIC DEVICES MARKET, BY SITE 159
8.1 INTRODUCTION 160
8.2 HAND & WRIST 160
8.2.1 RISING CASES OF RADIUS AND ULNA FRACTURES TO
SUPPORT MARKET GROWTH 160
8.3 SPINE 161
8.3.1 TECHNOLOGICAL INNOVATIONS IN SPINAL IMPLANTS AND HIGHER INCIDENCE OF SPINAL SURGERY TO FUEL MARKET GROWTH 161
8.4 FOOT & ANKLE 162
8.4.1 RISING PREFERENCE FOR FOOT & ANKLE RECONSTRUCTION TO
AUGMENT GROWTH 162
8.5 ARM & ELBOW 163
8.5.1 RISING INCIDENCE OF ARM FRACTURES TO ACCELERATE DEMAND FOR ORTHOPEDIC DEVICES 163
8.6 KNEE & THIGH 164
8.6.1 GROWING CASES OF COLLATERAL LIGAMENT INJURIES AND TENDON TEARS TO FUEL MARKET 164
8.7 HIP & PELVIS 165
8.7.1 RISING NUMBER OF PATIENTS UNDERGOING HIP REPLACEMENT SURGERY TO SUPPORT GROWTH 165
8.8 SHOULDER 166
8.8.1 INCREASING INCIDENCE OF SHOULDER INJURIES TO DRIVE MARKET 166
8.9 CRANIOMAXILLOFACIAL 167
8.9.1 INCREASING AWARENESS OF CRANIOMAXILLOFACIAL RECONSTRUCTIVE SURGERY TO PROPEL MARKET 167
9 ORTHOPEDIC DEVICES MARKET, BY APPLICATION 169
9.1 INTRODUCTION 170
9.2 FRACTURE TREATMENT & RECOVERY 170
9.2.1 RISING INCIDENCE OF FRACTURES TO BOOST DEMAND FOR
ORTHOPEDIC DEVICES 170
9.3 SPINAL FUSION, FIXATION, AND DECOMPRESSION 171
9.3.1 GROWTH IN SPINAL FUSION SURGERIES TO DRIVE MARKET 171
9.4 RHEUMATOID ARTHRITIS & OSTEOARTHRITIS 172
9.4.1 RISING POOL OF RHEUMATOID ARTHRITIS AND OSTEOARTHRITIS PATIENTS TO DRIVE MARKET 172
9.5 LIGAMENT INJURIES 173
9.5.1 INCREASING PARTICIPATION IN SPORTS AND PHYSICAL ACTIVITIES TO SUPPORT MARKET GROWTH 173
9.6 DIABETIC FOOT DISEASES 174
9.6.1 GROWING PREVALENCE OF DIABETIC FOOT ULCERS TO
SUPPORT MARKET GROWTH 174
9.7 NEUROLOGICAL DISORDERS 175
9.7.1 RISING INCIDENCE OF NEUROLOGICAL DISORDERS TO DRIVE MARKET 175
10 ORTHOPEDIC DEVICES MARKET, BY END USER 177
10.1 INTRODUCTION 178
10.2 HOSPITALS & SURGICAL CENTERS 178
10.2.1 RISING NUMBER OF ORTHOPEDIC SURGERIES COUPLED WITH INFRASTRUCTURE DEVELOPMENT TO DRIVE MARKET 178
10.3 AMBULATORY CARE CENTERS & TRAUMA UNITS 179
10.3.1 COST-EFFECTIVE TREATMENT OFFERED BY AMBULATORY CARE CENTERS TO PROPEL MARKET GROWTH 179
10.4 ORTHOPEDIC CLINICS 180
10.4.1 INCREASING NUMBER OF ORTHOPEDIC CLINICS TO SUPPORT
MARKET GROWTH 180
10.5 HOME CARE SETTINGS 181
10.5.1 RISING PREFERENCE FOR HOME CARE TO SUSTAIN MARKET GROWTH 181
10.6 OTHER END USERS 182
11 ORTHOPEDIC DEVICES MARKET, BY REGION 183
11.1 INTRODUCTION 184
11.2 NORTH AMERICA 184
11.2.1 MACROECONOMIC OUTLOOK FOR NORTH AMERICA 184
11.2.2 US 192
11.2.2.1 US to dominate North American market 192
11.2.3 CANADA 197
11.2.3.1 Rising incidence of degenerative bone diseases to support
market growth 197
11.3 EUROPE 201
11.3.1 MACROECONOMIC OUTLOOK FOR EUROPE 201
11.3.2 GERMANY 208
11.3.2.1 Germany to account for largest market share in Europe 208
11.3.3 FRANCE 212
11.3.3.1 Increasing prevalence of musculoskeletal disorders and significant adoption of orthopedic devices to support market growth 212
11.3.4 UK 217
11.3.4.1 Increasing awareness of orthopedic conditions to drive adoption of innovative treatments 217
11.3.5 ITALY 221
11.3.5.1 Increasing awareness of preventive care for musculoskeletal injuries to drive market 221
11.3.6 SPAIN 225
11.3.6.1 Growing preference for minimally invasive surgical procedures to drive market 225
11.3.7 REST OF EUROPE 229
11.4 ASIA PACIFIC 233
11.4.1 MACROECONOMIC OUTLOOK FOR ASIA PACIFIC 233
11.4.2 JAPAN 241
11.4.2.1 Rapidly growing geriatric population to propel market 241
11.4.3 CHINA 245
11.4.3.1 Expanding target patient population to drive market 245
11.4.4 INDIA 249
11.4.4.1 Increasing number of hospitals adopting robotic-assisted joint replacement surgery to support market growth 249
11.4.5 AUSTRALIA 254
11.4.5.1 Favorable government and private initiatives to promote
market growth 254
11.4.6 SOUTH KOREA 258
11.4.6.1 Rising R&D and funding to drive market 258
11.4.7 REST OF ASIA PACIFIC 262
11.5 LATIN AMERICA 265
11.5.1 MACROECONOMIC OUTLOOK FOR LATIN AMERICA 266
11.5.2 BRAZIL 273
11.5.2.1 Strong presence of global players to drive market 273
11.5.3 MEXICO 277
11.5.3.1 Favorable investment scenario for medical device manufacturers to support market growth 277
11.5.4 REST OF LATIN AMERICA 281
11.6 MIDDLE EAST & AFRICA 285
11.6.1 MACROECONOMIC OUTLOOK FOR MIDDLE EAST & AFRICA 286
11.6.2 GCC COUNTRIES 292
11.6.2.1 Growing public-private partnerships to propel the market growth 292
11.6.3 REST OF MIDDLE EAST & AFRICA 296
12 COMPETITIVE LANDSCAPE 301
12.1 OVERVIEW 301
12.2 KEY PLAYER STRATEGIES/RIGHT TO WIN (2024) 301
12.2.1 OVERVIEW OF STRATEGIES DEPLOYED BY KEY COMPANIES 302
12.3 REVENUE ANALYSIS, 2019−2023 304
12.4 MARKET SHARE ANALYSIS, 2023 305
12.4.1 RANKING OF KEY MARKET PLAYERS 306
12.5 COMPANY EVALUATION MATRIX: KEY PLAYERS, 2023 307
12.5.1 STARS 307
12.5.2 EMERGING LEADERS 307
12.5.3 PERVASIVE PLAYERS 307
12.5.4 PARTICIPANTS 307
12.5.5 COMPANY FOOTPRINT: KEY PLAYERS, 2023 309
12.5.5.1 Company footprint 309
12.5.5.2 Region footprint 310
12.5.5.3 Product footprint 311
12.5.5.4 Application footprint 312
12.5.5.5 Site footprint 313
12.5.5.6 End-user footprint 314
12.6 COMPANY EVALUATION MATRIX: STARTUPS/SMES, 2023 314
12.6.1 PROGRESSIVE COMPANIES 314
12.6.2 RESPONSIVE COMPANIES 314
12.6.3 DYNAMIC COMPANIES 315
12.6.4 STARTING BLOCKS 315
12.6.5 COMPETITIVE BENCHMARKING: STARTUPS/SMES, 2023 316
12.6.5.1 Detailed list of key startups/SMEs 316
12.6.5.2 Competitive benchmarking of key startups/SMEs 317
12.7 COMPANY VALUATION & FINANCIAL METRICS 318
12.7.1 COMPANY VALUATION 318
12.7.2 FINANCIAL METRICS 319
12.8 BRAND/PRODUCT COMPARISON 320
12.9 COMPETITIVE SCENARIO 321
12.9.1 PRODUCT LAUNCHES & APPROVALS 321
12.9.2 DEALS 323
13 COMPANY PROFILES 325
13.1 KEY PLAYERS 325
13.1.1 ZIMMER BIOMET 325
13.1.1.1 Business overview 325
13.1.1.2 Products offered 326
13.1.1.3 Recent developments 330
13.1.1.3.1 Product approvals 330
13.1.1.3.2 Deals 331
13.1.1.4 MnM view 331
13.1.1.4.1 Key strengths 331
13.1.1.4.2 Strategic choices 331
13.1.1.4.3 Weaknesses and competitive threats 331
13.1.2 STRYKER 332
13.1.2.1 Business overview 332
13.1.2.2 Products offered 333
13.1.2.3 Recent developments 338
13.1.2.3.1 Product launches 338
13.1.2.3.2 Deals 338
13.1.2.3.3 Expansions 339
13.1.2.4 MnM view 339
13.1.2.4.1 Key strengths 339
13.1.2.4.2 Strategic choices 339
13.1.2.4.3 Weaknesses and competitive threats 339
13.1.3 JOHNSON & JOHNSON MEDTECH 340
13.1.3.1 Business overview 340
13.1.3.2 Products offered 341
13.1.3.3 Recent developments 344
13.1.3.3.1 Product launches & approvals 344
13.1.3.3.2 Deals 345
13.1.3.4 MnM view 345
13.1.3.4.1 Key strengths 345
13.1.3.4.2 Strategic choices 345
13.1.3.4.3 Weaknesses and competitive threats 345
13.1.4 SMITH+NEPHEW 346
13.1.4.1 Business overview 346
13.1.4.2 Products offered 348
13.1.4.3 Recent developments 349
13.1.4.3.1 Product launches & approvals 349
13.1.4.3.2 Deals 350
13.1.4.3.3 Expansions 351
13.1.4.4 MnM view 351
13.1.4.4.1 Key strengths 351
13.1.4.4.2 Strategic choices 351
13.1.4.4.3 Weaknesses and competitive threats 351
13.1.5 B. BRAUN MELSUNGEN AG 352
13.1.5.1 Business overview 352
13.1.5.2 Products offered 353
13.1.5.3 Recent developments 355
13.1.5.3.1 Deals 355
13.1.5.4 MnM view 355
13.1.5.4.1 Key strengths 355
13.1.5.4.2 Strategic choices 355
13.1.5.4.3 Weaknesses and competitive threats 356
13.1.6 GLOBUS MEDICAL 357
13.1.6.1 Business overview 357
13.1.6.2 Products offered 358
13.1.6.3 Recent developments 361
13.1.6.3.1 Product launches & approvals 361
13.1.6.3.2 Deals 362
13.1.7 ARTHREX, INC. 363
13.1.7.1 Business overview 363
13.1.7.2 Products offered 363
13.1.7.3 Recent developments 368
13.1.7.3.1 Product approvals 368
13.1.8 ENOVIS 369
13.1.8.1 Business overview 369
13.1.8.2 Products offered 370
13.1.8.3 Recent developments 374
13.1.8.3.1 Product launches & approvals 374
13.1.8.3.2 Deals 375
13.1.8.3.3 Expansions 376
13.1.9 ACUMED LLC 377
13.1.9.1 Business overview 377
13.1.9.2 Products offered 377
13.1.9.3 Recent developments 379
13.1.9.3.1 Product launches 379
13.1.9.3.2 Deals 380
13.1.9.3.3 Expansions 380
13.1.10 ORTHOFIX MEDICAL INC. 381
13.1.10.1 Business overview 381
13.1.10.2 Products offered 382
13.1.10.3 Recent developments 385
13.1.10.3.1 Product launches & approvals 385
13.1.10.3.2 Deals 386
13.1.11 MICROPORT SCIENTIFIC CORPORATION 387
13.1.11.1 Business overview 387
13.1.11.2 Products offered 388
13.1.11.3 Recent developments 389
13.1.11.3.1 Product launches & approvals 389
13.1.11.3.2 Deals 390
13.1.12 CONMED CORPORATION 391
13.1.12.1 Business overview 391
13.1.12.2 Products offered 393
13.1.12.3 Recent developments 394
13.1.12.3.1 Deals 394
13.1.13 PARAGON 28, INC. 395
13.1.13.1 Business overview 395
13.1.13.2 Products offered 396
13.1.13.3 Recent developments 398
13.1.13.3.1 Product launches & approvals 398
13.1.13.3.2 Deals 399
13.1.14 MEDACTA INTERNATIONAL 400
13.1.14.1 Business overview 400
13.1.14.2 Products offered 401
13.1.14.3 Recent developments 402
13.1.14.3.1 Product launches & approvals 402
13.1.14.3.2 Deals 403
13.1.14.3.3 Expansions 403
13.1.15 MERIL LIFE SCIENCES PVT. LTD. 404
13.1.15.1 Business overview 404
13.1.15.2 Products offered 404
13.1.15.3 Recent developments 406
13.1.15.3.1 Expansions 406
13.1.16 MAXX ORTHOPEDICS, INC. 407
13.1.16.1 Business overview 407
13.1.16.2 Products offered 407
13.1.16.3 Recent developments 408
13.1.16.3.1 Product approvals 408
13.1.16.3.2 Deals 408
13.2 OTHER PLAYERS 409
13.2.1 FH ORTHO 409
13.2.2 SYMBIOS ORTHOPÉDIE S.A. 410
13.2.3 MADISON ORTHO 411
13.2.4 GREEN SURGICALS PVT. LTD. 413
13.2.5 SIORA SURGICAL PVT. LTD. 418
13.2.6 ORTHOPEDIATRICS CORP. 422
13.2.7 RESTOR3D 423
13.2.8 DOUBLE MEDICAL TECHNOLOGY INC. 424
13.2.9 TREACE MEDICAL CONCEPTS, INC. 427
13.2.10 AK MEDICAL 428
14 APPENDIX 430
14.1 DISCUSSION GUIDE 430
14.2 KNOWLEDGESTORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL 436
14.3 CUSTOMIZATION OPTIONS 438
14.4 RELATED REPORTS 438
14.5 AUTHOR DETAILS 440
LIST OF TABLES
TABLE 1 ORTHOPEDIC DEVICES MARKET: ROLE OF COMPANIES IN ECOSYSTEM 70
TABLE 2 ORTHOPEDIC DEVICES MARKET: KEY CONFERENCES AND EVENTS, 2025–2026 75
TABLE 3 IMPORT DATA FOR HS CODE 902110, BY COUNTRY,
2020–2023 (USD THOUSAND) 76
TABLE 4 EXPORT DATA FOR HS CODE 902110, BY COUNTRY,
2020–2023 (USD THOUSAND) 77
TABLE 5 INNOVATIONS AND PATENT REGISTRATIONS, JANUARY 2023–JANUARY 2025 80
TABLE 6 ORTHOPEDIC DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 81
TABLE 7 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR
KEY PRODUCT SEGMENTS (%) 84
TABLE 8 KEY BUYING CRITERIA FOR ORTHOPEDIC DEVICES 84
TABLE 9 AVERAGE SELLING PRICE TREND OF ORTHOPEDIC IMPLANTS, BY REGION,
2021–2023 (USD) 88
TABLE 10 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY KEY PLAYER,
2023 (USD) 89
TABLE 11 MEDICAL REIMBURSEMENT CODES FOR ORTHOPEDIC SERVICES, 2023 90
TABLE 12 ORTHOPEDIC DEVICES MARKET: CURRENT UNMET NEEDS 93
TABLE 13 NORTH AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 93
TABLE 14 EUROPE: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 15 ASIA PACIFIC: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 94
TABLE 16 LATIN AMERICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES,
AND OTHER ORGANIZATIONS 95
TABLE 17 MIDDLE EAST & AFRICA: KEY REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 96
TABLE 18 US FDA: MEDICAL DEVICE CLASSIFICATION 96
TABLE 19 US: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 97
TABLE 20 CANADA: MEDICAL DEVICE REGULATORY APPROVAL PROCESS 98
TABLE 21 JAPAN: MEDICAL DEVICE CLASSIFICATION UNDER PMDA 101
TABLE 22 CHINA: CLASSIFICATION OF MEDICAL DEVICES 101
TABLE 23 ORTHOPEDIC DEVICES MARKET, BY PRODUCT, 2022–2030 (USD MILLION) 106
TABLE 24 ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 107
TABLE 25 ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 107
TABLE 26 ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 108
TABLE 27 ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 108
TABLE 28 ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 109
TABLE 29 FOOT & ANKLE REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 110
TABLE 30 KNEE REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 111
TABLE 31 HIP REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 112
TABLE 32 HAND & WRIST REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 112
TABLE 33 ELBOW REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 113
TABLE 34 SHOULDER REPLACEMENT DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 114
TABLE 35 OTHER REPLACEMENT DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 115
TABLE 36 SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 115
TABLE 37 SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY REGION,
2022–2030 (USD MILLION) 116
TABLE 38 SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 116
TABLE 39 SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 117
TABLE 40 SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 117
TABLE 41 SPINAL FUSION DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 118
TABLE 42 SPINAL NON-FUSION DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 119
TABLE 43 ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 119
TABLE 44 ORTHOPEDIC FIXATION DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 120
TABLE 45 ORTHOPEDIC FIXATION DEVICES MARKET, BY SITE, 2022–2030 (USD MILLION) 120
TABLE 46 ORTHOPEDIC FIXATION DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 121
TABLE 47 ORTHOPEDIC FIXATION DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 121
TABLE 48 INTERNAL FIXATION DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 123
TABLE 49 EXTERNAL FIXATION DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 124
TABLE 50 ARTHROSCOPY INSTRUMENTS MARKET, BY REGION, 2022–2030 (USD MILLION) 125
TABLE 51 ARTHROSCOPY INSTRUMENTS MARKET, BY SITE, 2022–2030 (USD MILLION) 125
TABLE 52 ARTHROSCOPY INSTRUMENTS MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 126
TABLE 53 ARTHROSCOPY INSTRUMENTS MARKET, BY END USER,
2022–2030 (USD MILLION) 126
TABLE 54 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 127
TABLE 55 ORTHOPEDIC BRACES & SUPPORTS MARKET, BY REGION,
2022–2030 (USD MILLION) 127
TABLE 56 ORTHOPEDIC BRACES AND SUPPORT MARKET, BY SITE,
2022–2030 (USD MILLION) 128
TABLE 57 ORTHOPEDIC BRACES AND SUPPORT MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 128
TABLE 58 ORTHOPEDIC BRACES AND SUPPORT MARKET, BY END USER,
2022–2030 (USD MILLION) 129
TABLE 59 KNEE BRACES & SUPPORTS MARKET, BY REGION, 2022–2030 (USD MILLION) 130
TABLE 60 ANKLE BRACES & SUPPORTS MARKET, BY REGION, 2022–2030 (USD MILLION) 131
TABLE 61 FOOT WALKERS & ORTHOSES MARKET, BY REGION, 2022–2030 (USD MILLION) 132
TABLE 62 BACK, HIP, AND SPINE BRACES MARKET, BY REGION, 2022–2030 (USD MILLION) 133
TABLE 63 SHOULDER BRACES & SUPPORTS MARKET, BY REGION,
2022–2030 (USD MILLION) 134
TABLE 64 ELBOW BRACES & SUPPORTS MARKET, BY REGION, 2022–2030 (USD MILLION) 134
TABLE 65 HAND & WRIST BRACES & SUPPORTS MARKET, BY REGION,
2022–2030 (USD MILLION) 135
TABLE 66 FACIAL BRACES & SUPPORTS MARKET, BY REGION, 2022–2030 (USD MILLION) 136
TABLE 67 ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 136
TABLE 68 ORTHOPEDIC PROSTHETICS MARKET, BY REGION, 2022–2030 (USD MILLION) 137
TABLE 69 ORTHOPEDIC PROSTHETICS MARKET, BY SITE, 2022–2030 (USD MILLION) 137
TABLE 70 ORTHOPEDIC PROSTHETICS MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 138
TABLE 71 ORTHOPEDIC PROSTHETICS DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 138
TABLE 72 SOLID ANKLE CUSHION HEEL PROSTHESES MARKET, BY REGION,
2022–2030 (USD MILLION) 139
TABLE 73 SINGLE-AXIAL PROSTHESES MARKET, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 74 MULTI-AXIAL PROSTHESES MARKET, BY REGION, 2022–2030 (USD MILLION) 140
TABLE 75 DYNAMIC RESPONSE PROSTHESES MARKET, BY REGION,
2022–2030 (USD MILLION) 141
TABLE 76 MICROPROCESSOR-CONTROLLED PROSTHESES MARKET, BY REGION,
2022–2030 (USD MILLION) 142
TABLE 77 BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 142
TABLE 78 BONE GRAFT SUBSTITUTES MARKET, BY REGION, 2022–2030 (USD MILLION) 143
TABLE 79 BONE GRAFT SUBSTITUTES MARKET, BY SITE, 2022–2030 (USD MILLION) 143
TABLE 80 BONE GRAFT SUBSTITUTES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 144
TABLE 81 BONE GRAFT SUBSTITUTES MARKET, BY END USER, 2022–2030 (USD MILLION) 144
TABLE 82 AUTOGRAFTS MARKET, BY REGION, 2022–2030 (USD MILLION) 145
TABLE 83 ALLOGRAFTS MARKET, BY REGION, 2022–2030 (USD MILLION) 146
TABLE 84 SYNTHETIC GRAFTS MARKET, BY REGION, 2022–2030 USD MILLION) 146
TABLE 85 ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 147
TABLE 86 ORTHOBIOLOGICS MARKET, BY REGION, 2022–2030 (USD MILLION) 147
TABLE 87 ORTHOBIOLOGICS MARKET, BY SITE, 2022–2030 (USD MILLION) 148
TABLE 88 ORTHOBIOLOGICS MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 148
TABLE 89 ORTHOBIOLOGICS MARKET, BY END USER, 2022–2030 (USD MILLION) 149
TABLE 90 VISCOSUPPLEMENTATION PRODUCTS MARKET, BY REGION,
2022–2030 (USD MILLION) 150
TABLE 91 DEMINERALIZED BONE MATRIX MARKET, BY REGION, 2022–2030 (USD MILLION) 150
TABLE 92 BONE MORPHOGENETIC PROTEINS MARKET, BY REGION,
2022–2030 (USD MILLION) 151
TABLE 93 PLASMA-RICH PROTEIN MARKET, BY REGION, 2022–2030 (USD MILLION) 152
TABLE 94 BONE MARROW ASPIRATE CONCENTRATE MARKET, BY REGION,
2022–2030 (USD MILLION) 153
TABLE 95 HIP REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 155
TABLE 96 KNEE REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 155
TABLE 97 ANKLE REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 155
TABLE 98 SHOULDER REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 156
TABLE 99 ELBOW REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 156
TABLE 100 HAND & WRIST REPLACEMENT PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 156
TABLE 101 HIP ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 157
TABLE 102 KNEE ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 157
TABLE 103 ANKLE ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 157
TABLE 104 SHOULDER ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 158
TABLE 105 ELBOW ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 158
TABLE 106 HAND & WRIST ARTHROSCOPY PROCEDURES, BY REGION, 2022–2024
(NUMBER OF PROCEDURES) 158
TABLE 107 ORTHOPEDIC DEVICES MARKET, BY SITE, 2022–2030 (USD MILLION) 160
TABLE 108 ORTHOPEDIC DEVICES MARKET FOR HAND & WRIST INJURIES, BY REGION,
2022–2030 (USD MILLION) 161
TABLE 109 ORTHOPEDIC DEVICES MARKET FOR SPINAL INJURIES, BY REGION,
2022–2030 (USD MILLION) 162
TABLE 110 ORTHOPEDIC DEVICES MARKET FOR FOOT & ANKLE INJURIES, BY REGION,
2022–2030 (USD MILLION) 163
TABLE 111 ORTHOPEDIC DEVICES MARKET FOR ARM & ELBOW INJURIES, BY REGION,
2022–2030 (USD MILLION) 164
TABLE 112 ORTHOPEDIC DEVICES MARKET FOR KNEE & THIGH INJURIES, BY REGION,
2022–2030 (USD MILLION) 165
TABLE 113 ORTHOPEDIC DEVICES MARKET FOR HIP & PELVIS INJURIES, BY REGION,
2022–2030 (USD MILLION) 166
TABLE 114 ORTHOPEDIC DEVICES MARKET FOR SHOULDER INJURIES, BY REGION,
2022–2030 (USD MILLION) 167
TABLE 115 ORTHOPEDIC DEVICES MARKET FOR CRANIOMAXILLOFACIAL INJURIES,
BY REGION, 2022–2030 (USD MILLION) 168
TABLE 116 ORTHOPEDIC DEVICES MARKET, BY APPLICATION, 2022–2030 (USD MILLION) 170
TABLE 117 ORTHOPEDIC DEVICES MARKET FOR FRACTURE TREATMENT & RECOVERY,
BY REGION, 2022–2030 (USD MILLION) 171
TABLE 118 ORTHOPEDIC DEVICES MARKET FOR SPINAL FUSION, FIXATION, AND DECOMPRESSION, BY REGION, 2022–2030 (USD MILLION) 172
TABLE 119 ORTHOPEDIC DEVICES MARKET FOR RHEUMATOID ARTHRITIS & OSTEOARTHRITIS, BY REGION, 2022–2030 (USD MILLION) 173
TABLE 120 ORTHOPEDIC DEVICES MARKET FOR LIGAMENT INJURIES, BY REGION,
2022–2030 (USD MILLION) 174
TABLE 121 ORTHOPEDIC DEVICES MARKET FOR DIABETIC FOOT DISEASES, BY REGION, 2022–2030 (USD MILLION) 175
TABLE 122 ORTHOPEDIC DEVICES MARKET FOR NEUROLOGICAL DISORDERS, BY REGION, 2022–2030 (USD MILLION) 176
TABLE 123 ORTHOPEDIC DEVICES MARKET, BY END USER, 2022–2030 (USD MILLION) 178
TABLE 124 ORTHOPEDIC DEVICES MARKET FOR HOSPITALS & SURGICAL CENTERS,
BY REGION, 2022–2030 (USD MILLION) 179
TABLE 125 ORTHOPEDIC DEVICES MARKET FOR AMBULATORY CARE CENTERS & TRAUMA UNITS, BY REGION, 2022–2030 (USD MILLION) 180
TABLE 126 ORTHOPEDIC DEVICES MARKET FOR ORTHOPEDIC CLINICS BY REGION,
2022–2030 (USD MILLION) 181
TABLE 127 ORTHOPEDIC DEVICES MARKET FOR HOME CARE SETTINGS, BY REGION,
2022–2030 (USD MILLION) 181
TABLE 128 ORTHOPEDIC DEVICES MARKET FOR OTHER END USERS, BY REGION,
2022–2030 (USD MILLION) 182
TABLE 129 ORTHOPEDIC DEVICES MARKET, BY REGION, 2022–2030 (USD MILLION) 184
TABLE 130 NORTH AMERICA: KEY MACROINDICATORS 185
TABLE 131 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 187
TABLE 132 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 187
TABLE 133 NORTH AMERICA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 188
TABLE 134 NORTH AMERICA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 188
TABLE 135 NORTH AMERICA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 189
TABLE 136 NORTH AMERICA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 189
TABLE 137 NORTH AMERICA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 190
TABLE 138 NORTH AMERICA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 190
TABLE 139 NORTH AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 190
TABLE 140 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 191
TABLE 141 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 191
TABLE 142 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 192
TABLE 143 US: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 193
TABLE 144 US: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 194
TABLE 145 US: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 194
TABLE 146 US: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 195
TABLE 147 US: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 195
TABLE 148 US: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 196
TABLE 149 US: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 150 US: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 196
TABLE 151 CANADA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 197
TABLE 152 CANADA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 153 CANADA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 198
TABLE 154 CANADA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 199
TABLE 155 CANADA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 199
TABLE 156 CANADA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 200
TABLE 157 CANADA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 200
TABLE 158 CANADA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 200
TABLE 159 EUROPE: KEY MACROINDICATORS 202
TABLE 160 EUROPE: ORTHOPEDIC DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 202
TABLE 161 EUROPE: ORTHOPEDIC DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 203
TABLE 162 EUROPE: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 203
TABLE 163 EUROPE: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 204
TABLE 164 EUROPE: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 204
TABLE 165 EUROPE: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 205
TABLE 166 EUROPE: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 205
TABLE 167 EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 206
TABLE 168 EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 206
TABLE 169 EUROPE: ORTHOPEDIC DEVICES MARKET, BY SITE, 2022–2030 (USD MILLION) 207
TABLE 170 EUROPE: ORTHOPEDIC DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 207
TABLE 171 EUROPE: ORTHOPEDIC DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 208
TABLE 172 GERMANY: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 209
TABLE 173 GERMANY: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 209
TABLE 174 GERMANY: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 210
TABLE 175 GERMANY: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 210
TABLE 176 GERMANY: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 211
TABLE 177 GERMANY: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 211
TABLE 178 GERMANY: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 212
TABLE 179 GERMANY: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 212
TABLE 180 FRANCE: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 213
TABLE 181 FRANCE: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 214
TABLE 182 FRANCE: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 214
TABLE 183 FRANCE: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 215
TABLE 184 FRANCE: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 215
TABLE 185 FRANCE: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 216
TABLE 186 FRANCE: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 216
TABLE 187 FRANCE: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 216
TABLE 188 UK: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 217
TABLE 189 UK: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 218
TABLE 190 UK: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 218
TABLE 191 UK: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 219
TABLE 192 UK: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 219
TABLE 193 UK: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 220
TABLE 194 UK: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 220
TABLE 195 UK: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 220
TABLE 196 ITALY: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 221
TABLE 197 ITALY: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 222
TABLE 198 ITALY: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 222
TABLE 199 ITALY: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 223
TABLE 200 ITALY: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 223
TABLE 201 ITALY: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 224
TABLE 202 ITALY: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 224
TABLE 203 ITALY: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 224
TABLE 204 SPAIN: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 225
TABLE 205 SPAIN: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 226
TABLE 206 SPAIN: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 226
TABLE 207 SPAIN: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 227
TABLE 208 SPAIN: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 227
TABLE 209 SPAIN: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 228
TABLE 210 SPAIN: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 228
TABLE 211 SPAIN: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 228
TABLE 212 REST OF EUROPE: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 229
TABLE 213 REST OF EUROPE: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 230
TABLE 214 REST OF EUROPE: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 230
TABLE 215 REST OF EUROPE: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 231
TABLE 216 REST OF EUROPE: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 231
TABLE 217 REST OF EUROPE: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 232
TABLE 218 REST OF EUROPE: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 232
TABLE 219 REST OF EUROPE: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 232
TABLE 220 ASIA PACIFIC: KEY MACROINDICATORS 234
TABLE 221 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 236
TABLE 222 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 236
TABLE 223 ASIA PACIFIC: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 237
TABLE 224 ASIA PACIFIC: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 237
TABLE 225 ASIA PACIFIC: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 238
TABLE 226 ASIA PACIFIC: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 238
TABLE 227 ASIA PACIFIC: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 239
TABLE 228 ASIA PACIFIC: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 239
TABLE 229 ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 239
TABLE 230 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 240
TABLE 231 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 240
TABLE 232 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 241
TABLE 233 JAPAN: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 242
TABLE 234 JAPAN: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 242
TABLE 235 JAPAN: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 243
TABLE 236 JAPAN: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 243
TABLE 237 JAPAN: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 244
TABLE 238 JAPAN: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 244
TABLE 239 JAPAN: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 245
TABLE 240 JAPAN: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 245
TABLE 241 CHINA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 246
TABLE 242 CHINA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 246
TABLE 243 CHINA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 247
TABLE 244 CHINA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 247
TABLE 245 CHINA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 248
TABLE 246 CHINA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 248
TABLE 247 CHINA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 249
TABLE 248 CHINA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 249
TABLE 249 INDIA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 250
TABLE 250 INDIA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 251
TABLE 251 INDIA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 251
TABLE 252 INDIA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 252
TABLE 253 INDIA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 252
TABLE 254 INDIA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 253
TABLE 255 INDIA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE, 2022–2030 (USD MILLION) 253
TABLE 256 INDIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 253
TABLE 257 AUSTRALIA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 254
TABLE 258 AUSTRALIA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 255
TABLE 259 AUSTRALIA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 255
TABLE 260 AUSTRALIA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 256
TABLE 261 AUSTRALIA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 256
TABLE 262 AUSTRALIA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 257
TABLE 263 AUSTRALIA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 257
TABLE 264 AUSTRALIA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 257
TABLE 265 SOUTH KOREA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 258
TABLE 266 SOUTH KOREA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 259
TABLE 267 SOUTH KOREA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 259
TABLE 268 SOUTH KOREA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 260
TABLE 269 SOUTH KOREA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 260
TABLE 270 SOUTH KOREA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 261
TABLE 271 SOUTH KOREA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 261
TABLE 272 SOUTH KOREA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 261
TABLE 273 REST OF ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 262
TABLE 274 REST OF ASIA PACIFIC: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 262
TABLE 275 REST OF ASIA PACIFIC: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 263
TABLE 276 REST OF ASIA PACIFIC: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 263
TABLE 277 REST OF ASIA PACIFIC: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE, 2022–2030 (USD MILLION) 264
TABLE 278 REST OF ASIA PACIFIC: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 264
TABLE 279 REST OF ASIA PACIFIC: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 265
TABLE 280 REST OF ASIA PACIFIC: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 265
TABLE 281 LATIN AMERICA: KEY MACROINDICATORS 267
TABLE 282 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY COUNTRY,
2022–2030 (USD MILLION) 267
TABLE 283 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 268
TABLE 284 LATIN AMERICA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 268
TABLE 285 LATIN AMERICA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 269
TABLE 286 LATIN AMERICA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 269
TABLE 287 LATIN AMERICA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 270
TABLE 288 LATIN AMERICA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 270
TABLE 289 LATIN AMERICA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 271
TABLE 290 LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 271
TABLE 291 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 272
TABLE 292 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 272
TABLE 293 LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 273
TABLE 294 BRAZIL: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 274
TABLE 295 BRAZIL: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 274
TABLE 296 BRAZIL: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 275
TABLE 297 BRAZIL: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 275
TABLE 298 BRAZIL: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 276
TABLE 299 BRAZIL: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 276
TABLE 300 BRAZIL: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 277
TABLE 301 BRAZIL: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 277
TABLE 302 MEXICO: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 278
TABLE 303 MEXICO: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 278
TABLE 304 MEXICO: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 279
TABLE 305 MEXICO: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 279
TABLE 306 MEXICO: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 280
TABLE 307 MEXICO: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 280
TABLE 308 MEXICO: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 281
TABLE 309 MEXICO: ORTHOBIOLOGICS MARKET, BY TYPE, 2022–2030 (USD MILLION) 281
TABLE 310 REST OF LATIN AMERICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 282
TABLE 311 REST OF LATIN AMERICA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 282
TABLE 312 REST OF LATIN AMERICA: ORTHOPEDIC REPLACEMENT DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 283
TABLE 313 REST OF LATIN AMERICA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 283
TABLE 314 REST OF LATIN AMERICA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 315 REST OF LATIN AMERICA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 284
TABLE 316 REST OF LATIN AMERICA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 285
TABLE 317 REST OF LATIN AMERICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 285
TABLE 318 MIDDLE EAST & AFRICA: KEY MACROINDICATORS 286
TABLE 319 MIDDLE EAST & AFRICA: ORTHOPEDIC DEVICES MARKET, BY REGION,
2022–2029 (USD MILLION) 287
TABLE 320 MIDDLE EAST & AFRICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT,
2022–2030 (USD MILLION) 287
TABLE 321 MIDDLE EAST & AFRICA: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 288
TABLE 322 MIDDLE EAST & AFRICA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 288
TABLE 323 MIDDLE EAST & AFRICA: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 289
TABLE 324 MIDDLE EAST & AFRICA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE, 2022–2030 (USD MILLION) 289
TABLE 325 MIDDLE EAST & AFRICA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 290
TABLE 326 MIDDLE EAST & AFRICA: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 290
TABLE 327 MIDDLE EAST & AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 290
TABLE 328 MIDDLE EAST & AFRICA: ORTHOPEDIC DEVICES MARKET, BY SITE,
2022–2030 (USD MILLION) 291
TABLE 329 MIDDLE EAST & AFRICA: ORTHOPEDIC DEVICES MARKET, BY APPLICATION,
2022–2030 (USD MILLION) 291
TABLE 330 MIDDLE EAST & AFRICA: ORTHOPEDIC DEVICES MARKET, BY END USER,
2022–2030 (USD MILLION) 292
TABLE 331 GCC COUNTRIES: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE,
2022–2030 (USD MILLION) 293
TABLE 332 GCC COUNTRIES: ORTHOPEDIC FIXATION DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 293
TABLE 333 GCC COUNTRIES: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE,
2022–2030 (USD MILLION) 294
TABLE 334 GCC COUNTRIES: ORTHOPEDIC PROSTHETICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 294
TABLE 335 GCC COUNTRIES: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE,
2022–2030 (USD MILLION) 295
TABLE 336 GCC COUNTRIES: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 295
TABLE 337 GCC COUNTRIES: BONE GRAFT SUBSTITUTES MARKET, BY TYPE,
2022–2030 (USD MILLION) 296
TABLE 338 GCC COUNTRIES: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 296
TABLE 339 REST OF MIDDLE EAST AND AFRICA: ORTHOPEDIC DEVICES MARKET, BY PRODUCT TYPE, 2022–2030 (USD MILLION) 297
TABLE 340 REST OF MIDDLE EAST AND AFRICA: ORTHOPEDIC FIXATION DEVICES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 297
TABLE 341 REST OF MIDDLE EAST AND AFRICA: ORTHOPEDIC REPLACEMENT DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 342 REST OF MIDDLE EAST AND AFRICA: ORTHOPEDIC PROSTHETICS MARKET,
BY TYPE, 2022–2030 (USD MILLION) 298
TABLE 343 REST OF MIDDLE EAST AND AFRICA: ORTHOPEDIC BRACES & SUPPORTS MARKET, BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 344 REST OF MIDDLE EAST AND AFRICA: SPINAL IMPLANTS & SURGICAL DEVICES MARKET, BY TYPE, 2022–2030 (USD MILLION) 299
TABLE 345 REST OF MIDDLE EAST AND AFRICA: BONE GRAFT SUBSTITUTES MARKET,
BY TYPE, 2022–2030 (USD MILLION) 300
TABLE 346 REST OF MIDDLE EAST AND AFRICA: ORTHOBIOLOGICS MARKET, BY TYPE,
2022–2030 (USD MILLION) 300
TABLE 347 OVERVIEW OF STRATEGIES ADOPTED BY PLAYERS IN ORTHOPEDIC DEVICES MARKET (2021–2025) 302
TABLE 348 ORTHOPEDIC DEVICES MARKET: DEGREE OF COMPETITION 305
TABLE 349 ORTHOPEDIC DEVICES MARKET: REGION FOOTPRINT, 2023 310
TABLE 350 ORTHOPEDIC DEVICES MARKET: PRODUCT FOOTPRINT, 2023 311
TABLE 351 ORTHOPEDIC DEVICES MARKET: APPLICATION FOOTPRINT, 2023 312
TABLE 352 ORTHOPEDIC DEVICES MARKET: SITE FOOTPRINT, 2023 313
TABLE 353 ORTHOPEDIC DEVICES MARKET: END-USER FOOTPRINT, 2023 314
TABLE 354 JOINT REPLACEMENT DEVICES MARKET: DETAILED LIST OF KEY STARTUP/SMES 316
TABLE 355 ORTHOPEDIC DEVICES MARKET: COMPETITIVE BENCHMARKING OF
KEY STARTUPS/SMES 317
TABLE 356 ORTHOPEDIC DEVICES MARKET: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021–JANUARY 2025 321
TABLE 357 ORTHOPEDIC DEVICES MARKET: DEALS, JANUARY 2021–JANUARY 2025 323
TABLE 358 ZIMMER BIOMET: COMPANY OVERVIEW 325
TABLE 359 ZIMMER BIOMET: PRODUCTS OFFERED 326
TABLE 360 ZIMMER BIOMET: PRODUCT APPROVALS, JANUARY 2021−FEBRUARY 2025 330
TABLE 361 ZIMMER BIOMET: DEALS, JANUARY 2021− FEBRUARY 2025 331
TABLE 362 STRYKER: COMPANY OVERVIEW 332
TABLE 363 STRYKER: PRODUCTS OFFERED 333
TABLE 364 STRYKER: PRODUCT LAUNCHES, JANUARY 2021−FEBRUARY 2025 338
TABLE 365 STRYKER: DEALS, JANUARY 2021− FEBRUARY 2025 338
TABLE 366 STRYKER: EXPANSIONS, JANUARY 2021− FEBRUARY 2025 339
TABLE 367 JOHNSON & JOHNSON MEDTECH: COMPANY OVERVIEW 340
TABLE 368 JOHNSON & JOHNSON MEDTECH: PRODUCTS OFFERED 341
TABLE 369 JOHNSON & JOHNSON MEDTECH: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−FEBRUARY 2025 344
TABLE 370 JOHNSON & JOHNSON MEDTECH: DEALS, JANUARY 2021−FEBRUARY 2025 345
TABLE 371 SMITH+NEPHEW: COMPANY OVERVIEW 346
TABLE 372 SMITH+NEPHEW: PRODUCTS OFFERED 348
TABLE 373 SMITH+NEPHEW: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021− FEBRUARY 2025 349
TABLE 374 SMITH+NEPHEW: DEALS, JANUARY 2021−FEBRUARY 2025 350
TABLE 375 SMITH+NEPHEW: EXPANSIONS, JANUARY 2021−FEBRUARY 2025 351
TABLE 376 B. BRAUN MELSUNGEN AG: COMPANY OVERVIEW 352
TABLE 377 B. BRAUN MEDICAL: PRODUCTS OFFERED 353
TABLE 378 B. BRAUN: DEALS, JANUARY 2021−FEBRUARY 2025 355
TABLE 379 GLOBUS MEDICAL: COMPANY OVERVIEW 357
TABLE 380 GLOBUS MEDICAL: PRODUCTS OFFERED 358
TABLE 381 GLOBUS MEDICAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021−FEBRUARY 2025 361
TABLE 382 GLOBUS MEDICAL: DEALS, JANUARY 2021−FEBRUARY 2025 362
TABLE 383 ARTHREX, INC.: COMPANY OVERVIEW 363
TABLE 384 ARTHREX, INC.: PRODUCTS OFFERED 363
TABLE 385 ARTHREX, INC.: PRODUCT APPROVALS, JANUARY 2021−FEBRUARY 2025 368
TABLE 386 ENOVIS: COMPANY OVERVIEW 369
TABLE 387 ENOVIS: PRODUCTS OFFERED 370
TABLE 388 ENOVIS: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021−FEBRUARY 2025 374
TABLE 389 ENOVIS: DEALS, JANUARY 2021−FEBRUARY 2025 375
TABLE 390 ENOVIS: EXPANSIONS, JANUARY 2021−FEBRUARY 2025 376
TABLE 391 ACUMED LLC: COMPANY OVERVIEW 377
TABLE 392 ACUMED LLC: PRODUCTS OFFERED 377
TABLE 393 ACUMED LLC: PRODUCT LAUNCHES, JANUARY 2021 − FEBRUARY 2025 379
TABLE 394 ACUMED: DEALS, JANUARY 2021− FEBRUARY 2025 380
TABLE 395 ACUMED: EXPANSIONS, JANUARY 2021−FEBRUARY 2025 380
TABLE 396 ORTHOFIX MEDICAL INC.: COMPANY OVERVIEW 381
TABLE 397 ORTHOFIX MEDICAL INC.: PRODUCTS OFFERED 382
TABLE 398 ORTHOFIX MEDICAL INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021− FEBRUARY 2025 385
TABLE 399 ORTHOFIX MEDICAL INC.: DEALS, JANUARY 2021−FEBRUARY 2025 386
TABLE 400 MICROPORT SCIENTIFIC CORPORATION: COMPANY OVERVIEW 387
TABLE 401 MICROPORT SCIENTIFIC CORPORATION: PRODUCTS OFFERED 388
TABLE 402 MICROPORT SCIENTIFIC CORPORATION: PRODUCT LAUNCHES & APPROVALS, JANUARY 2021− FEBRUARY 2025 389
TABLE 403 MICROPORT SCIENTIFIC CORPORATION: DEALS, JANUARY 2021−FEBRUARY 2025 390
TABLE 404 CONMED CORPORATION: COMPANY OVERVIEW 391
TABLE 405 CONMED CORPORATION: PRODUCTS OFFERED 393
TABLE 406 CONMED CORPORATION: DEALS, JANUARY 2021−FEBRUARY 2025 394
TABLE 407 PARAGON 28, INC.: COMPANY OVERVIEW 395
TABLE 408 PARAGON 28, INC.: PRODUCTS OFFERED 396
TABLE 409 PARAGON 28, INC.: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021− DECEMBER 2024 398
TABLE 410 PARAGON 28, INC.: DEALS, JANUARY 2021− DECEMBER 2024 399
TABLE 411 MEDACTA INTERNATIONAL: COMPANY OVERVIEW 400
TABLE 412 MEDACTA INTERNATIONAL: PRODUCTS OFFERED 401
TABLE 413 MEDACTA INTERNATIONAL: PRODUCT LAUNCHES & APPROVALS,
JANUARY 2021− FEBRUARY 2025 402
TABLE 414 MEDACTA INTERNATIONAL: DEALS, JANUARY 2021−FEBRUARY 2025 403
TABLE 415 MEDACTA INTERNATIONAL: EXPANSIONS, JANUARY 2021−FEBRUARY 2025 403
TABLE 416 MERIL LIFE SCIENCES PVT. LTD.: COMPANY OVERVIEW 404
TABLE 417 MERIL LIFE SCIENCES: PRODUCTS OFFERED 404
TABLE 418 MERIL LIFE SCIENCES PVT. LTD.: EXPANSIONS, JANUARY 2021− FEBRUARY 2025 406
TABLE 419 MAXX ORTHOPEDICS, INC.: COMPANY OVERVIEW 407
TABLE 420 MAXX ORTHOPEDICS, INC.: PRODUCTS OFFERED 407
TABLE 421 MAXX ORTHOPEDICS, INC.: PRODUCT APPROVALS, JANUARY 2021−
FEBRUARY 2025 408
TABLE 422 MAXX ORTHOPEDICS, INC.: DEALS, JANUARY 2021−FEBRUARY 2025 408
TABLE 423 FH ORTHO: COMPANY OVERVIEW 409
TABLE 424 SYMBIOS ORTHOPÉDIE S.A.: COMPANY OVERVIEW 410
TABLE 425 MADISON ORTHO: COMPANY OVERVIEW 411
TABLE 426 GREEN SURGICALS PVT. LTD.: COMPANY OVERVIEW 413
TABLE 427 SIORA SURGICAL PVT. LTD.: COMPANY OVERVIEW 418
TABLE 428 ORTHOPEDIATRICS CORP.: COMPANY OVERVIEW 422
TABLE 429 RESTOR3D: COMPANY OVERVIEW 423
TABLE 430 DOUBLE MEDICAL TECHNOLOGY INC.: COMPANY OVERVIEW 424
TABLE 431 TREACE MEDICAL CONCEPTS, INC.: COMPANY OVERVIEW 427
TABLE 432 AK MEDICAL: COMPANY OVERVIEW 428
LIST OF FIGURES
FIGURE 1 ORTHOPEDIC DEVICES MARKET: MARKET RESEARCH METHODOLOGY 39
FIGURE 2 ORTHOPEDIC DEVICES MARKET: RESEARCH DESIGN 40
FIGURE 3 BREAKDOWN OF PRIMARY INTERVIEWS: SUPPLY-SIDE AND
DEMAND-SIDE PARTICIPANTS 44
FIGURE 4 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE,
DESIGNATION, AND REGION 45
FIGURE 5 RESEARCH METHODOLOGY: HYPOTHESIS BUILDING 46
FIGURE 6 ORTHOPEDIC DEVICES MARKET SIZE ESTIMATION: APPROACH 1
(COMPANY REVENUE ESTIMATION) 47
FIGURE 7 ORTHOPEDIC DEVICES MARKET SIZE ESTIMATION: BOTTOM-UP APPROACH 48
FIGURE 8 TOP-DOWN APPROACH 49
FIGURE 9 DATA TRIANGULATION 51
FIGURE 10 ORTHOPEDIC DEVICES MARKET, BY PRODUCT, 2024 VS. 2030 (USD MILLION) 54
FIGURE 11 ORTHOPEDIC DEVICES MARKET, BY SITE, 2024 VS. 2030 (USD MILLION) 55
FIGURE 12 ORTHOPEDIC DEVICES MARKET, BY APPLICATION, 2024 VS. 2030 (USD MILLION) 56
FIGURE 13 ORTHOPEDIC DEVICES MARKET, BY END USER, 2024 VS. 2030 (USD MILLION) 57
FIGURE 14 GEOGRAPHIC SNAPSHOT OF ORTHOPEDIC DEVICES MARKET 58
FIGURE 15 RISING PREVALENCE OF ORTHOPEDIC DISEASES AND DISORDERS TO
DRIVE MARKET GROWTH 59
FIGURE 16 ORTHOPEDIC REPLACEMENT DEVICES TO REGISTER SIGNIFICANT GROWTH IN NORTH AMERICAN MARKET DURING FORECAST PERIOD 60
FIGURE 17 KNEE & THIGH AND HIP & PELVIS INJURIES TO SHOWCASE HIGHEST DEMAND FOR ORTHOPEDIC DEVICES 61
FIGURE 18 AMBULATORY CARE CENTERS & TRAUMA UNITS SEGMENT TO REGISTER SIGNIFICANT GROWTH IN APAC MARKET 62
FIGURE 19 CHINA TO WITNESS HIGHEST GROWTH DURING FORECAST PERIOD 62
FIGURE 20 ORTHOPEDIC DEVICES MARKET: DRIVERS, RESTRAINTS,
OPPORTUNITIES, AND CHALLENGES 63
FIGURE 21 ORTHOPEDIC DEVICES MARKET: ECOSYSTEM ANALYSIS 69
FIGURE 22 ORTHOPEDIC DEVICES MARKET: SUPPLY CHAIN ANALYSIS 70
FIGURE 23 ORTHOPEDIC DEVICES MARKET: VALUE CHAIN ANALYSIS 72
FIGURE 24 IMPORT DATA FOR HS CODE 902110, BY COUNTRY,
2020–2023 (USD THOUSAND) 77
FIGURE 25 EXPORT DATA FOR HS CODE 902110, BY COUNTRY,
2020–2023 (USD THOUSAND) 78
FIGURE 26 ORTHOPEDIC DEVICES MARKET: PATENT ANALYSIS, 2014–2025 79
FIGURE 27 TRENDS/DISRUPTIONS IMPACTING CUSTOMERS’ BUSINESSES 81
FIGURE 28 ORTHOPEDIC DEVICES MARKET: PORTER’S FIVE FORCES ANALYSIS 82
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS FOR ORTHOPEDIC DEVICES 83
FIGURE 30 KEY BUYING CRITERIA FOR ORTHOPEDIC DEVICES 84
FIGURE 31 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY REGION, 2023 (USD) 88
FIGURE 32 AVERAGE SELLING PRICE OF ORTHOPEDIC IMPLANTS, BY PRODUCT, 2023 (USD) 89
FIGURE 33 INVESTMENT & FUNDING SCENARIO IN ORTHOPEDIC DEVICES MARKET, 2019−2023 (USD MILLION) 91
FIGURE 34 NUMBER OF INVESTOR DEALS IN ORTHOPEDIC DEVICES MARKET,
BY KEY PLAYER, 2019−2023 92
FIGURE 35 VALUE OF INVESTOR DEALS IN ORTHOPEDIC DEVICES MARKET, BY KEY PLAYER, 2019–2023 (USD MILLION) 92
FIGURE 36 CANADA: REGULATORY APPROVAL PROCESS FOR MEDICAL DEVICES 98
FIGURE 37 EUROPE: CE APPROVAL PROCESS FOR MEDICAL DEVICES 100
FIGURE 38 ORTHOPEDIC DEVICES MARKET: IMPACT OF AI AND USE CASES 103
FIGURE 39 NORTH AMERICA: ORTHOPEDIC DEVICES MARKET SNAPSHOT 186
FIGURE 40 ASIA PACIFIC: ORTHOPEDIC DEVICES MARKET SNAPSHOT 235
FIGURE 41 REVENUE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC DEVICES MARKET (2019−2023) 304
FIGURE 42 MARKET SHARE ANALYSIS OF KEY PLAYERS IN ORTHOPEDIC
DEVICES MARKET, 2023 305
FIGURE 43 RANKING OF KEY PLAYERS IN ORTHOPEDIC DEVICES MARKET, 2023 306
FIGURE 44 ORTHOPEDIC DEVICES MARKET: COMPANY EVALUATION MATRIX
(KEY PLAYERS), 2023 308
FIGURE 45 ORTHOPEDIC DEVICES MARKET: COMPANY FOOTPRINT, 2023 309
FIGURE 46 ORTHOPEDIC DEVICES MARKET: COMPANY EVALUATION MATRIX (STARTUPS/SMES), 2023 315
FIGURE 47 EV/EBITDA OF KEY VENDORS, 2025 318
FIGURE 48 5-YEAR STOCK BETA OF KEY VENDORS, 2025 319
FIGURE 49 ORTHOPEDIC DEVICES MARKET: BRAND/PRODUCT COMPARATIVE ANALYSIS 320
FIGURE 50 ZIMMER BIOMET: COMPANY SNAPSHOT (2023) 326
FIGURE 51 STRYKER: COMPANY SNAPSHOT (2023) 333
FIGURE 52 JOHNSON & JOHNSON MEDTECH: COMPANY SNAPSHOT (2023) 341
FIGURE 53 SMITH+NEPHEW: COMPANY SNAPSHOT (2023) 347
FIGURE 54 B. BRAUN: COMPANY SNAPSHOT (2023) 353
FIGURE 55 GLOBUS MEDICAL: COMPANY SNAPSHOT (2023) 358
FIGURE 56 ENOVIS: COMPANY SNAPSHOT (2023) 370
FIGURE 57 ORTHOFIX MEDICAL INC.: COMPANY SNAPSHOT (2023) 382
FIGURE 58 MICROPORT SCIENTIFIC CORPORATION: COMPANY SNAPSHOT (2023) 388
FIGURE 59 CONMED CORPORATION: COMPANY SNAPSHOT (2023) 392
FIGURE 60 PARAGON 28, INC.: COMPANY SNAPSHOT (2023) 395
FIGURE 61 MEDACTA INTERNATIONAL: COMPANY SNAPSHOT (2023) 401
MarketsandMarkets（マーケッツアンドマーケッツ）は広範な市場を対象にした市場調査レポートを出版しています。世界中の企業に高い評価を得ており、著名メディアでの引用頻度も高い、インドの最大手級の市場調査会社です。
※MarketsandMarketsの調査レポートはほぼ全タイトルご注文後、最短3時間～12時間以内（営業日基準）にご納品可能です。
ライセンス別価格表
調査会社の事情により予告なしに変更されることがございます。最新の状況およびその他のパターンについてはお問い合わせください。
ライセンスタイプ1
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD4,950 | USD6,650 | USD8,150 | USD10,000 |
ライセンスタイプ2
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD7,150 | USD8,500 | USD9,650 | USD11,000 |
ライセンスタイプ3
| シングルユーザ | マルチユーザ | コーポレート | エンタープライズサイト |
| USD9,000 | USD10,500 | USD12,000 | USD13,500 |
ミニレポート ※定性調査にフォーカスした調査レポートです。詳細はお問合せください。
| シングルユーザ | コーポレート |
| USD 2,650 | USD 4,250 |
ご購入に関するご案内
価格・納期について
- 価格
- ウェブサイトに記載の外貨（定価）を見積日のTTSレートで換算後消費税を加えた金額が弊社からの請求金額になります。見積金額はレート変動に関係なく見積書発行日より2週間有効です。手数料（ハンドリングチャージ）無料。
- ライセンス
- シングルユーザライセンス
- 1名のみレポートファイルのご利用が可能です。
- マルチユーザライセンス
- 同一企業内（関連会社除く）5名までレポートファイルのご利用が可能です。
- コーポレートライセンス
- 同一企業および100％持株会社間・人数無制限でレポートファイルのご利用が可能です。
- エンタープライズサイトライセンス
- 特別ライセンスです。適用範囲についてはお問合せください。
- シングルユーザライセンス
- 納品形態
- Eメール
- 納期
- 最短3時間以内にご納品可能です。通常ご注文後24時間以内（営業日基準）
ご注文方法
- レポートページ内のお問い合わせフォームより見積もりをご請求ください。確認次第見積書と発注書をお送りいたします。既に弊社の見積書をお持ちの場合にはEメールまたはFAXでご注文ください。
その他
- 商品の性質上、ご注文後のキャンセル/返品/交換はできません。ご了承ください。
株式会社SEMABIZはMarketsandMarketsの日本に拠点をおく販売代理店として、MarketsandMarketsのレポートを販売しております。サンプルページのご依頼、見積り、レポートに関するご質問など購入前のご相談はいつでもお気軽にご連絡ください。
最新調査レポート
- コンクリートシーラー市場 – 2030年までの世界予測 2025-04-21
- 自動車用ヒートシールド市場 – 2032年までの世界予測 2025-04-21
- XEVアフターマーケットの進化に関する競争力情報 – 2035年までの世界予測 2025-04-17
- アプリケーションライフサイクル管理市場 – 2029年までの世界予測 2025-04-17
- ヒンダードアミン光安定剤（HALS）市場 – 2030年までの世界予測 2025-04-17